Please login to the form below
patient safety
This page shows the latest patient safety news and features for those working in and with pharma, biotech and healthcare.
Time running out for ‘no-deal’ Brexit medicines laws
However the General Pharmaceutical Council (GPhC) has argued against the latter, claiming that it could put patient safety at risk as prescribers may no longer be qualified to do so in
Latest news
-
Brexit contributes to surge in generic drug prices
Safeguarding pharmacies in this way will be an important step to ensure that in a time of crisis, patient safety and medicines supply can be maintained, and pressure on other healthcare
-
FDA takes aim at pharma’s biosimilar-delaying tactics
FDA Commissioner Scott Gottlieb. “ While the limited distribution programmes can have a role in promoting patient safety, too many branded products are still misusing these programmes as rhetorical smokescreens to hide ... In concrete terms, the FDA
-
Medical devices probe uncovers need for “drastic regulatory changes”
Derek Alderson, president of the Royal College of Surgeons (pictured above), said, “All implantable devices should be registered and tracked to monitor efficacy and patient safety in the long term.”. ... Medical devices undergo strict regulatory
-
UK and EU’s future relationship ‘must protect patients’
While there are positives in the political declaration, the detail is missing. We are asking Government to give explicit commitments on issues of public health and medicines safety which we think ... vital that patients are included in the next
-
Hancock's 'Tech Revolution' for NHS to be limited by budgets
These robust standards will ensure that every part of the NHS can use the best technology to improve patient safety, reduce delays and speed up appointments. ... Connected systems ensure that clinicians have immediate access to all relevant and
More from news
Approximately 71 fully matching, plus 217 partially matching documents found.
Latest Intelligence
-
AstraZeneca’s oncology renaissance
So how did AstraZeneca achieve this turnaround? In 2010 Mene Pangalos introduced a ‘5R framework’ for R&D: right target, right patient, right tissue, right safety, right commercial potential.
-
In conversation with Pfizer’s Erik Nordkamp
Both in terms of productivity gains, healthcare outcomes, and patient and healthcare professional experience. ... This is an educational approach for junior doctors and is designed to increase patient safety and reduce human error by improving
-
Changes to look out for in Medical Devices Regulations
at the time and damaged the confidence of patients, consumers and healthcare professionals in the safety of medical devices’. ... fear for patient safety.
-
Transparency and accountability: tackling opacity and blame head-on
First do no harm’ is a fundamental tenet of medicine that rightly enshrines patient safety. ... For example, many clinicians are now using tools like WhatsApp to more efficiently answer questions, collaborate with colleagues and improve patient care
-
Brexit Means Brexit
As the ABPI says: “It is now critical that both sides prioritise patient safety in phase two of the negotiations.”. ... But it should also begin, privately at least, to stress the potential consumer impacts an alternative position might bring; the
More from intelligence
Approximately 1 fully matching, plus 24 partially matching documents found.
Latest appointments
-
Dr Ameet Nathwani moves from Novartis to Sanofi
As chief medical officer Dr Nathwani will be responsible for the pharmaceutical firm's medical, patient safety and medical quality assurance as well as the transparency and compliance standards of
-
NDA Group appoints Bill Griffiths as general manager, UK
Based in Leatherhead, Surrey, Griffiths will be responsible for managing the European regulatory affairs and patient safety consultancy's business in the UK with effect from 1 March.
-
AstraZeneca appoints Sean Bohen as chief medical officer
As CMO he will ensure patient safety across AZ's entire portfolio and additionally be responsible for pushing medicines from late-stage development through to regulatory approval.
-
NHS England names director for new models of care
layers” of processes and improve patient safety and experience.
-
Amgen appoints ex US surgeon general
Amgen has named former US surgeon general Steven Galson as senior VP, global regulatory affairs and safety. ... This direct experience in regulatory affairs and public health will benefit Amgen as Galson takes over responsibility for the company's
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest from PMHub
-
Healthcare excellence celebrated at 2018 HSJ Awards
The Value Awards recognises achievements in improved efficiency that also benefit the patient. ... Patient Safety Awards. Recognising the hardworking staff of the NHS the Patient Safety Awards represents innovative projects, dedicated people and
-
HSJ Awards Finalists Announced
The Value Awards recognises achievements in improved efficiency that also benefit the patient. . ... Patient Safety Awards Recognising the hardworking staff of the NHS the Patient Safety Awards represents innovative projects, dedicated people and
-
What will the NHS’s Capped Expenditure Process (CEP) mean for pharma?
Redundancies and cuts to staff numbers; limiting or blocking outsourcing and patient choice; rationing services and systematically extending waiting times for planned care are among the other potential implications of CEP. ... Balancing doctors’
-
How will the NHS’s new medicines savings drive affect pharma?
that are prescribed without a patient support programme. . ... Engagement tactics must balance clinicians’ demand for products that show strong clinical benefit and patient safety against medicines management teams’ focus on the cost savings that
-
Part Two: The First Amendment: Physician education using off-label indications to ensure that patients receive the most effective treatment.
company’s fiduciary duty to ensure patient safety, including the facilitation of proper education to the physician.
More from PMHub
Approximately 1 fully matching, plus 11 partially matching documents found.
Featured jobs
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Global Business Development Director – Health Education
-
excellent commission
-
Account Manager / Account Director
-
Competative
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
-
Business Director
-
Competitive Salary Offered
-
Account Director, Medical Education
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Account Director
-
Competitive Salary Offered
-
Senior Account Manager
-
Competitive Salary Offered
-
Medical Writer
-
Salary TBC
Subscribe to our email news alerts
- Pfizer takeover rumour ignites Amarin shares
- Welcome to the Communique Awards - Communiqué Awards 2018
- NICE rejects Novartis migraine treatment Aimovig
- GSK upbeat on its return to oncology market
- AstraZeneca unveils reorg, hires controversial José Baselga as cancer chief
- AZ’s Sean Bohen to exit after business overhaul; report
PMHub
COUCH.
WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...
Latest intelligence
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
- Escaping the spin cycle of sub-optimal launch
- ...
Quick links
Infographics
